A compilation of the research developments in breast cancer research from Google Alerts for the week ending 27 September 2013.
[Google Alerts doesn’t always have the most up-to-date research developments, and is heavy on the first-person stories, fund-raising and charity events, so if I’ve missed something out, my apologies. You are always welcome to post any new developments that I’ve missed out in the comments box and I’ll include them in the compilation, with grateful thanks and an acknowledgement.]
This week seems to be radiotherapy week. But it’s also shark week:
Photo credit: National Geographic wallpaper
1. Breast Cancer: Sharks’ Antibodies Could Hold Key
First it was shark’s fin soup, then shark cartilage, now it’s shark antibodies as a cure-all. Not a good time to be a shark.
Scientists at Aberdeen University believe that antibodies which help sharks fight off cancerous cells could do the same job in the human body.
They are beginning a three-year study to monitor how the antibody, called IgNAR, might be used to inhibit the growth of cancer cells.
The researchers believe it could be useful in targeting HER-2 positive breast cancer, a common form of the disease suffered by one in four breast cancer sufferers.
2. The test that could spare HALF of breast cancer patients from chemotherapy – by judging how far the tumour may spread
Shadow of branches on floor of Black Forest, so much like the network of arteries in the human body
TACE leaftlet 1
TACE leaflet 2
Updated 1 January 2015 re. importance of having a companion with you to make sure that your appointments during TACE run smoothly. There have been reports of patients being left on trolleys in the hospital corridors, the language problem, and patients being overlooked and having to discharge themselves.
Of all the treatments at Hallwang, Trans-arterial chemoembolisation (or TACE) was the one I dreaded the most.
A summary of the developments in breast cancer research from Google Alerts for the week ending 20 September 2013.
1. Giving women with breast cancer a shorter course of radiotherapy may be BETTER, study finds
“Women with breast cancer get as much benefit from three weeks of radiotherapy treatment as from the international standard five-week course, research has found.
Update 5 February, 2015: please note that I have been receiving reports from patients that Hallwang Clinic’s services are not meeting expectations and Grace Gawler no longer runs Medi-Tours to Hallwang. Therefore, before you go to Hallwang, please get it in writing that the oncologist and Prof Vogl will be there throughout your stay.
Think of a desert island filled with survivors of a shipwreck. Life is filled with challenges. In the midst of this stress, there is conflict. These survivors have one goal in common: to stay alive.
Just like the desert island survivors, there is one goal in a German cancer clinic: to stay alive. The weeks spent in the clinic are crammed full of treatments in order to beat the cancer. There may be challenges from the side-effects of the treatments.
Under these challenging circumstances, it would take a saint to remain calm and joyful 100% of the time.
A summary of the developments in breast cancer research from Google Alerts for the week ending 13 September 2013.
1. Hormone therapy may NOT pose higher cancer risk in some women
“Taking hormones to treat the symptoms of menopause is thought to increase women’s risk of breast cancer, but this risk doesn’t rise equally in all women, a new study finds.
Updated 17 August 2016: This is a tip from a reader of this blog (thank you, Benoit!): if you live in the European Union, there is another supplier of Nutrivene’s curcumin (the one that Dr Josh Trutt MD prefers). This is a French company, Optim Curcuma. I have done the sums (I will post the calculations), and unfortunately with Brexit, the GBP pound (£) is weak and this poor exchange rate means that you will end up paying more than if you bought off Amazon for Nutrivene Longvida. Also, Optim Curcuma only has 400mg per capsule vs Nutrivene Longvida’s 500mg. But if you are in a non-UK country, then Optim Curcuma might be a good option.
Updated 13 November 2014 with my cheapest source of Nutrivene curcumin: this is the cheapest source of Nutrivene curcumin – eVitamin.com: Now Foods CurcuBrain – it costs £13.14 (plus £4.95 for shipping – 5-7 business days). Each capsule only contains 400mg of curcumin vs Nutrivene’s own-brand Longvida which contains 500mg/capsule. However, Nutrivene Longvida in the UK costs £37. So the cost savings is amazing. Use this code 960497 and get US$5 off your order.
Curcumin has been touted as one of the best anti-cancer supplements. It has the ability to suppress proliferation of a wide variety of tumour cells and has remarkable anti-inflammatory action.
According to the prestigious MD Anderson Medical Centre: “there is no cancer that is not affected by curcumin.”
For that reason, curcumin is the #1 anti-cancer spice.
There is a host of curcumin supplements on the market. So which one should you be using? And how much should you be using?
Epstein Barr Virus
Updated 18 April 2014 re. Antisense treatment
(please note that I was under the assumption that the anti-viral treatment at Hallwang was the same as their Antisense treatment – this may not be the case, hence this re-write. With many thanks to SH who drew this to my attention)
Numerous studies have now shown that some cancers can be caused by viruses.
These viruses insert themselves into the DNA of cells, and start replicating. They turn off the cell’s protective mechanisms and cause the cells to divide without stopping. The result is the same as cancer which is caused by uncontrolled cell growth.
Or they may damage chromosomes during the cell’s replication, resulting in powerful gene promoters which trigger oncogenes.
Viruses linked to cancer include:
A summary of the developments in breast cancer research from Google Alerts for the week ending 6 September 2013.
1. Skipping breast cancer drug, Tamoxifen costs lives
GcMAF yoghurt success!
MAF314 (large jar left), Compound 2 (large jar right), Compound 1 (small jars front)
Updated March 2016 – For more information on GcMAF, please join the GcMAF and GcMAF Cancer forums on Facebook – they are closed groups, so you have to wait for your membership to be confirmed. They contain up-to-date information on sources of GcMAF, and also feedback and contributions by people who are using GcMAF.
Update 8 May 2014: Bravo Probiotics (the maker of GcMAF yoghurt) now have a new EasyKit that contains powdered colostrum – it signficantly cuts the time needed to make the yoghurt and also the cost of the yoghurt as liquid colostrum is very expensive.
Updated 22 March with new, cheaper source of liquid colostrum in the UK
Updated 16 March 2014 with information on yoghurt makers, and links to more recent posts on Bravo Probiotic
Updated 20 Feb 2014: Please note that there is a difference between the propagating process for Maf 314 and Bravo Probiotic. For Bravo: Compound 1 must be cultured afresh each time from the powder and not from the yoghurt. Compound 1 contains GcMAF. Compound 2 can have a life-cycle of up to 8 weeks. Therefore it is necessary to buy the Bravo Probiotic culture if you want to do this properly, you can’t rely on a culture that is a year old (like I have). I highly-recommend buying a culture from Bravo – that way, you know that the GcMAF and probiotics are active.
Updated 26 January 2014 with more photos about the ideal vs the actual real-life process of making GcMAF yoghurt, and observations from the Fulda Integrative Conference 2013.
And there are 3 videos on how to make Bravo Probiotic, check out: http://www.bravoprobiotic.com/index.php/storage-of-products/9-sezione1/6-2-how-to-prepare-bravo-probiotic
See also my post (March 2014): GCMAF AT WORK — BRAVO PROBIOTIC — MYTHS OF THE DANGERS OF DAIRY PRODUCTS FOR CANCER PATIENTS (A TALK BY PROF. MARCO RUGGIERO)
I’ve blogged previously about GcMAF, a protein in our immune system.
GcMAF stands for glycoprotein macrophage activating factor.
GcMAF activates macrophages (white blood cells that eat cancer cells). However, viruses and malignant cells like cancer send out an enzyme called Nagalase that blocks production of GcMAF.